These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31170612)

  • 1. Eight novel single chain antibody fragments recognising VP2 of foot-and-mouth disease virus serotypes A, O, and SAT 2.
    Salem R; El-Kholy AA; Ibrahim M
    Virology; 2019 Jul; 533():145-154. PubMed ID: 31170612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction, Expression and Evaluation of Recombinant VP2 Protein for serotype-independent Detection of FMDV Seropositive Animals in Egypt.
    Salem R; El-Kholy AA; Omar OA; Abu El-Naga MN; Ibrahim M; Osman G
    Sci Rep; 2019 Jul; 9(1):10135. PubMed ID: 31300744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of high-affinity single chain Fv against foot-and-mouth disease virus.
    Jung JG; Jeong GM; Yim SS; Jeong KJ
    Enzyme Microb Technol; 2016 Mar; 84():50-5. PubMed ID: 26827774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of porcine monoclonal antibodies revealed two distinct serotype-independent epitopes on VP2 of foot-and-mouth disease virus.
    Li K; Zhu G; Zhou S; Sun P; Wang H; Bao H; Fu Y; Li P; Bai X; Ma X; Zhang J; Li D; Chen Y; Liu Z; Cao Y; Lu Z
    J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34280085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of monoclonal antibodies against foot-and-mouth disease virus SAT 2 and the development of a lateral flow strip test for virus detection.
    Yang M; Mudabuka B; Quizon K; Nfon C
    Transbound Emerg Dis; 2019 May; 66(3):1158-1166. PubMed ID: 30462886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus.
    Xue M; Wang H; Li W; Zhou G; Tu Y; Yu L
    Virol J; 2012 Sep; 9():191. PubMed ID: 22963009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a serotype-independent linear epitope of foot-and-mouth disease virus.
    Yang B; Wang M; Liu W; Xu Z; Wang H; Yang D; Ma W; Zhou G; Yu L
    Arch Virol; 2017 Dec; 162(12):3875-3880. PubMed ID: 28884236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrecognized circulation of SAT 1 foot-and-mouth disease virus in cattle herds around Queen Elizabeth National Park in Uganda.
    Dhikusooka MT; Ayebazibwe C; Namatovu A; Belsham GJ; Siegismund HR; Wekesa SN; Balinda SN; Muwanika VB; Tjørnehøj K
    BMC Vet Res; 2016 Jan; 12():5. PubMed ID: 26739166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralising monoclonal antibody 8E8.
    Yang D; Zhang C; Zhao L; Zhou G; Wang H; Yu L
    Virus Res; 2011 Jan; 155(1):291-9. PubMed ID: 20974198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Responses to Amino Acid Substitutions in the VP0- and VP3-Coding Regions of PanAsia-1 Strains of Foot-and-Mouth Disease Virus Serotype O.
    Bai XW; Bao HF; Li PH; Ma XQ; Sun P; Bai QF; Zhang M; Yuan H; Chen DD; Li K; Chen YL; Cao YM; Fu YF; Zhang J; Li D; Lu ZJ; Liu ZX; Luo JX
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges for Serology-Based Characterization of Foot-and-Mouth Disease Outbreaks in Endemic Areas; Identification of Two Separate Lineages of Serotype O FMDV in Uganda in 2011.
    Namatovu A; Belsham GJ; Ayebazibwe C; Dhikusooka MT; Wekesa SN; Siegismund HR; Muwanika VB; Tjørnehøj K
    Transbound Emerg Dis; 2015 Oct; 62(5):522-34. PubMed ID: 24118785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved reverse transcription loop-mediated isothermal amplification assay for sensitive and specific detection of serotype O foot-and-mouth disease virus.
    Lim DR; Kim HR; Park MJ; Chae HG; Ku BK; Nah JJ; Ryoo SY; Wee SH; Park YR; Jeon HS; Kim JJ; Jeon BY; Lee HW; Yeo SG; Park CK
    J Virol Methods; 2018 Oct; 260():6-13. PubMed ID: 29964077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and Molecular Characterization of Foot and Mouth Disease Viruses from Outbreaks in Some States of Northern Nigeria 2013-2015.
    Ehizibolo DO; Haegeman A; De Vleeschauwer AR; Umoh JU; Kazeem HM; Okolocha EC; Van Borm S; De Clercq K
    Transbound Emerg Dis; 2017 Dec; 64(6):1979-1990. PubMed ID: 28097814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tailored reverse transcription loop-mediated isothermal amplification for sensitive and specific detection of serotype A foot-and-mouth disease virus circulating in pool 1 region countries.
    Lim DR; Kim HR; Park MJ; Chae HG; Ku BK; Nah JJ; Ryoo S; Wee SH; Park CK
    Transbound Emerg Dis; 2018 Dec; 65(6):1898-1908. PubMed ID: 30054975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a foot-and-mouth disease virus SAT serotype-specific 3ABC assay to differentiate infected from vaccinated animals.
    Chitray M; Grazioli S; Willems T; Tshabalala T; De Vleeschauwer A; Esterhuysen JJ; Brocchi E; De Clercq K; Maree FF
    J Virol Methods; 2018 May; 255():44-51. PubMed ID: 29428400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype-independent detection of foot-and-mouth disease virus.
    Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
    J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation.
    Kotecha A; Zhang F; Juleff N; Jackson T; Perez E; Stuart D; Fry E; Charleston B; Seago J
    J Gen Virol; 2016 Jul; 97(7):1557-1565. PubMed ID: 27002540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.